Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2006

View Archived Issues

Vascular endothelial growth factor antisense active, well tolerated in cancer patients

Antiinfluenza activity of traditional Korean medicinal herb extracts

A role for Omi/HtrA2 in skin inflammation following UVB irradiation

Alnylam licenses RNAi delivery technology from CBR Institute

DepoMed finalizes phase III protocol for Gabapentin GR study

M.D. Anderson Cancer Center spearheading new brain tumor treatments

Animal models reveal anti-infective efficacy of REP-9

Experiments show potential of ST-246 against orthopoxvirus infection

PharmaFrontiers presents data on T-cell and stem cell technology

Effects on biomarkers point to R-115866 activity in acne

Angiotech and Genzyme collaborate on innovative surgical oncology treatments

Qnexa produces weight loss in phase II study

NG2-73 significantly reduces time to onset of persistent sleep

CCR5 antagonist INCB-9471 begins phase I study

CTA-002 produces tumor suppression in prostate cancer model

New phase I/II study evaluating picoplatin for colorectal cancer

Laureate Pharma and Iconic Therapeutics sign hI-con1 manufacturing agreement

NephroGenex licenses Pyridorin rights

Fast track designation for Cell Genesys' GVAX immunotherapy for prostate cancer

Diatos acquires rights to DaunoXome

Elocalcitol shows efficacy in overactive bladder phase II study

Vanadium complex with insulin-mimetic activities

SurModics grants Bausch & Lomb genistein license in retinal diseases

Fast track status for BiovaxID

Recent patents report novel analgesic agents

Novel agents for treating neurological disorders disclosed in recent patent literature

Recent patents describe new diabetic treatment options

Taisho reports preclinical data on prostanoid receptor agonist for atopic dermatitis

New foscarnet derivative with activity against resistant HIV reported by Chimerix

Novel HIV-1 protease inhibitor demonstrates efficacy and good cross-resistance profile in vitro

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...